CRABP2 and neoplasm: CRABP2 has been known as the central player of RA tumor suppression, and, in contrast, FABP5 has been known as an RA tumor promotion signaling; these molecules function by delivering RA to its corresponding nuclear receptors, i.e., RAR-β and PPAR-β/δ, respectively [30,31,32].